The manufacturer has identified that certain Abiomed heart pumps with differential pressure sensors have the potential to display inaccurate information.
Medical device manufacturers use cytotoxicity testing to help prove that devices that come into contact with the human body are biocompatible. Testing results are critical for gaining market access, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results